» Articles » PMID: 26163401

Phenotypic Resistance in Mycobacteria: is It Because I Am Old or Fat That I Resist You?

Overview
Date 2015 Jul 12
PMID 26163401
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We aimed to explore the phenomenon of phenotypic resistance to antimycobacterial antibiotics and to determine whether this was associated with cell age or the presence of lipid bodies.

Methods: The accumulation of lipid-body-positive [lipid-rich (LR)] cells was followed using cell staining and flow cytometry. LR cells of Mycobacterium smegmatis, Mycobacterium marinum, Mycobacterium fortuitum and Mycobacterium bovis (BCG) were separated from non-lipid-body-containing [lipid-poor (LP)] cells and their MBCs determined. We also compared the MBCs for LR and LP cells from 'old' and 'young' cultures.

Results: The LR cells of all species were more resistant to antibiotics than LP cells. For BCG, the susceptibility ratios were as follows: rifampicin, 5×; isoniazid, 16.7×; ethambutol, 5×; and ciprofloxacin, 5×. Phenotypic resistance was found in LR cells irrespective of cell age.

Conclusions: We have shown that phenotypic antibiotic resistance is associated with the presence of lipid bodies irrespective of cell age. These data have important implications for our understanding of relapse in mycobacterial infections.

Citing Articles

Involvement of Mycobacterium smegmatis small noncoding RNA B11 in triacylglycerol accumulation and altered cell wall permeability.

Wu Z, Liu W, Tan Q, Chen Y, Lai X, Hong J BMC Microbiol. 2025; 25(1):124.

PMID: 40057673 PMC: 11889869. DOI: 10.1186/s12866-025-03826-7.


Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing ?.

Hammond R, Kloprogge F, Pasqua O, Gillespie S Front Antibiot. 2025; 1():928365.

PMID: 39816411 PMC: 11732046. DOI: 10.3389/frabi.2022.928365.


Monitoring Live Mycobacteria in Real-Time Using a Microfluidic Acoustic-Raman Platform.

Chen M, Baron V, Hammarstrom B, Hammond R, Glynne-Jones P, Gillespie S Methods Mol Biol. 2024; 2833:109-119.

PMID: 38949705 DOI: 10.1007/978-1-0716-3981-8_11.


Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.

Heyckendorf J, Georghiou S, Frahm N, Heinrich N, Kontsevaya I, Reimann M Clin Microbiol Rev. 2022; 35(3):e0022721.

PMID: 35311552 PMC: 9491169. DOI: 10.1128/cmr.00227-21.


Lipid droplets and the transcriptome of Mycobacterium tuberculosis from direct sputa: a literature review.

Mekonnen D, Derbie A, Mihret A, Yimer S, Tonjum T, Gelaw B Lipids Health Dis. 2021; 20(1):129.

PMID: 34602073 PMC: 8487580. DOI: 10.1186/s12944-021-01550-5.